The DEA Finally Drew a Line Between Kratom Leaf and 7-OH. The Gas-Station Shelf Is About to Feel It.

If you buy kratom at a gas station, you already know the shelf has two kinds of product that look alike: the leaf powder you grew up hearing about, and the tiny bottles and tablets that hit like something else entirely. On October 9, the Justice Department said it would stop treating them as one thing.

A line finally exists, and it is drawn in milligrams, not in moral panic.

Here is the mechanics. 7-OH (7-hydroxymitragynine) is a compound in kratom that acts on the same opioid receptors as prescription painkillers. It occurs naturally in the leaf at trace levels; the products that worry regulators are the ones where it has been concentrated or added. Under the notice, which the Federal Register published October 14, 7-OH and a related compound called MGPI would go into Schedule I, the strictest tier, only if a product has more than 1 milligram per gram (solids) or per milliliter (liquids) of either, or if the ratio of mitragynine, kratom’s main alkaloid, to 7-OH or MGPI falls below 100 to 1. That threshold came from an HHS recommendation, and DOJ says its purpose is to separate products with trace amounts from ones that were intentionally enhanced.

Attorney General Todd Blanche put the politics in one sentence: “Dangerous and addictive opioids do not belong behind convenience store counters.” The American Kratom Association welcomed the revision because the earlier approach could have criminalized natural leaf with trace amounts, per the Partnership to End Addiction’s summary, and some drug policy advocates and lawmakers want limits on all kratom.

Now the gate, because a notice is not a ban. These are Notices of Intent with a 30-day period, not final orders. MGPI and two related compounds, MGM-15 and MGM-16, have been in Schedule I since August 26 and stay there while the notice runs. 7-OH itself has never had a temporary scheduling order. Until DEA issues one, and until your state does what states do, what is legal to sell where you live can differ from what Washington said.

For a provider, the move this week is simple: add one question to intake. Ask what form of kratom someone uses and how often, because a person taking concentrated 7-OH products daily is closer to opioid dependence than to a cup of tea, and may need to be treated as such. If a shelf empties on someone with that pattern, the risk is sudden withdrawal or a switch to something worse. A clinician can help with that; you can send people to our find-help tool without a lecture.

If that person is you, nothing in this notice makes you a criminal for wanting off a product that was legally sold to you.